Arafura stock sell-off continues, broker tips 35% upside

Recent weakness could be a buying opportunity for investors according to one broker.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points
  • The Arafura share price hit a 52-week high a few weeks ago
  • Since then, its shares have lost over 20% of their value
  • Bell Potter believes this is a buying opportunity for investors

The Arafura Rare Earths Ltd (ASX: ARU) share price is under pressure on Tuesday.

At the time of writing, the rare earths developer's shares are down 5% to 53.5 cents.

This means the Arafura share price has now dropped almost 24% since hitting a 52-week high less than a month ago.

This has been driven by concerns over comments out of electric vehicle giant Tesla, which revealed plans to phase out rare earths from future vehicles.

And while this decline is disappointing, it could prove to be a great buying opportunity for investors.

Two male ASX 200 analysts stand in an office looking at various computer screens showing share prices.

Image source: Getty Images

Broker tips major upside for Arafura share price

According to a recent note out of Bell Potter, its analysts have described the Tesla-induced selloff as "a knee jerk reaction."

As a result, it recently upgraded its shares to a speculative buy rating with a 72 cents price target. Based on the current Arafura share price, this implies potential upside of almost 35% over the next 12 months.

The broker commented:

The recent 16% sell-off in ARU in reaction to the Tesla Investor Day presentation was a knee jerk reaction and in our view, was overdone. We maintain our valuation for ARU of $0.72/share and return to a Speculative BUY recommendation.

Bell Potter continues to believe that demand for rare earths will grow materially and support strong prices even without Tesla in the equation. It explains:

The result reduced our NdPr demand estimates by 10ktpa, which would still require the addition of 4.3x of Nolans capacity over the next 7 years. Given the scale, grade and advanced nature of the Nolans project we would still view this as a difficult task to achieve thus concluding price support for NdPr should be maintained.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

Red buy button on an Apple keyboard with a finger on it.
Broker Notes

Brokers name 3 ASX shares to buy right now

Here's why brokers are feeling bullish about these three shares this week.

Read more »

A smiling woman holds a Facebook like sign above her head.
Broker Notes

Why these ASX shares are rated as buys in April

Let's see what makes them bullish on these names right now.

Read more »

Australian dollar notes in the pocket of a man's jeans, symbolising dividends.
Broker Notes

Are CBA shares still a good buy for passive income?

A leading analyst delivers his verdict on CBA’s passive income appeal.

Read more »

A financial expert or broker looks worried as he checks out a graph showing market volatility.
Broker Notes

Morgans names 2 ASX shares to buy and 1 to accumulate

What is the broker recommending investors do with these shares?

Read more »

A man in a business suit rides a graphic image of an arrow that is rebounding on a graph.
Broker Notes

2 ASX 200 shares to buy ahead of anticipated rally: expert

After a 9.1% drop between 27 February and 23 March, the ASX 200 reversed course last Tuesday.

Read more »

A group of people in a corporate setting do a collective high five.
Broker Notes

3 reasons to buy Ramsay Health Care shares today

A leading analyst expects Ramsay Health Care shares to keep outperforming in the months ahead.

Read more »

A woman presenting company news to investors looks back at the camera and smiles.
Broker Notes

Bell Potter says this ASX 200 stock can rise 38% and pay a 6% dividend yield

Major upside and a generous dividend yield could be on offer with this name.

Read more »

Middle age caucasian man smiling confident drinking coffee at home.
Broker Notes

Is this ASX defence stock the next DroneShield?

Bell Potter thinks this stock could be the next to rocket. Let's find out why.

Read more »